Khushi Dabla EMED Study: A Randomized Controlled Trial Investigating Buprenorphine/Naloxone Microdosing in Emergency Departments
Buprenorphine/naloxone (commonly known as Suboxone) is a life-saving medication for people with opioid use disorder (OUD). Our trial identifies high-risk patients with OUD in emergency departments (EDs) who may be candidates for initiating preventative intervention. The trial addresses an urgent need to expand access to life-saving opioid agonist therapy by reducing barriers to starting buprenorphine/naloxone in EDs.
WEBCAST VIEWING REQUIREMENTS TEST LINK, Click to confirm browser and connectivity to watch this event
10/10/2023 6:35:00 PM
Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform